Intravenous administration of triptonide attenuates CFA-induced pain hypersensitivity through inhibiting AKT signaling pathway in mice

Yuejuan Ling(Nantong University), Bao‐Chun Jiang(Rutgers, The State University of New Jersey)

Research Square (Research Square)

January 3, 2020

10.21203/rs.2.19974/v1

Cited by 0

Related Papers

CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5

|Journal of Clinical Investigation|2016|333

Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer

|Carcinogenesis|2010|69

Antioxidant Cascade Nanoenzyme Antagonize Inflammatory Pain by Modulating MAPK/p‐65 Signaling Pathway

|Advanced Science|2023|57

Demethylation of G-Protein-Coupled Receptor 151 Promoter Facilitates the Binding of Krüppel-Like Factor 5 and Enhances Neuropathic Pain after Nerve Injury in Mice

|Journal of Neuroscience|2018|53

<p>Intravenous Administration of Triptonide Attenuates CFA-Induced Pain Hypersensitivity by Inhibiting DRG AKT Signaling Pathway in Mice</p>

|Journal of Pain Research|2020|15